These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 33469509)

  • 1. Pluronic
    Sultan MH; Mahdi WA; Kwon YM
    Bioimpacts; 2021; 11(1):59-64. PubMed ID: 33469509
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-lasting Insulin Treatment Via a Single Subcutaneous Administration of Liposomes in Thermoreversible Pluronic® F127 Based Hydrogel.
    Chen X; Wong BCK; Chen H; Zhang S; Bian Z; Zhang G; Lin C; Riaz MK; Tyagi D; Lu A; Yang Z
    Curr Pharm Des; 2018 Feb; 23(39):6079-6085. PubMed ID: 28486917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Time-action profile of an oral enteric insulin formulation in healthy Chinese volunteers.
    Li J; Wang Y; Han L; Sun X; Yu H; Yu Y
    Clin Ther; 2012 Dec; 34(12):2333-8. PubMed ID: 23195963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic and pharmacokinetic properties of a premixed 85/15 human insulin preparation.
    Mudaliar SR; Mohideen P; Baxi SC; Joyce M; Armstrong DA; Strange P; Henry RR
    Clin Ther; 2001 Mar; 23(3):404-12. PubMed ID: 11318075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proportional dose-response relationship and lower within-patient variability of insulin detemir and NPH insulin in subjects with type 1 diabetes mellitus.
    Wutte A; Plank J; Bodenlenz M; Magnes C; Regittnig W; Sinner F; Rønn B; Zdravkovic M; Pieber TR
    Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):461-7. PubMed ID: 17647145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Absorption of insulin from pluronic F-127 gels following subcutaneous administration in rats.
    Barichello JM; Morishita M; Takayama K; Nagai T
    Int J Pharm; 1999 Jul; 184(2):189-98. PubMed ID: 10387948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled delivery of recombinant hirudin based on thermo-sensitive Pluronic F127 hydrogel for subcutaneous administration: In vitro and in vivo characterization.
    Liu Y; Lu WL; Wang JC; Zhang X; Zhang H; Wang XQ; Zhou TY; Zhang Q
    J Control Release; 2007 Feb; 117(3):387-95. PubMed ID: 17207884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocturnal glucose metabolism after bedtime injection of insulin glargine or neutral protamine hagedorn insulin in patients with type 2 diabetes.
    Linn T; Fischer B; Soydan N; Eckhard M; Ehl J; Kunz C; Bretzel RG
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3839-46. PubMed ID: 18611975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of a cocrystalline suspension of [LysB28,ProB29]-human insulin analogue.
    DeFelippis MR; Bakaysa DL; Bell MA; Heady MA; Li S; Pye S; Youngman KM; Radziuk J; Frank BH
    J Pharm Sci; 1998 Feb; 87(2):170-6. PubMed ID: 9519149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.
    Lepore M; Pampanelli S; Fanelli C; Porcellati F; Bartocci L; Di Vincenzo A; Cordoni C; Costa E; Brunetti P; Bolli GB
    Diabetes; 2000 Dec; 49(12):2142-8. PubMed ID: 11118018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural characterization of insulin NPH formulations.
    Norrman M; Hubálek F; Schluckebier G
    Eur J Pharm Sci; 2007 Apr; 30(5):414-23. PubMed ID: 17339105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Action profile of a semisynthetic human isophane zinc insulin compared with customary isophane insulin].
    Gin H; Delafaye C; Morlat P; Aubertin J
    Diabete Metab; 1992; 18(6):445-50. PubMed ID: 1297601
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Examining the Effects of Hyperbaric Oxygen Therapy on the Cardiovascular System and Oxidative Stress in Insulin-Treated and Non-Treated Diabetic Rats.
    Ristic P; Savic M; Bolevich S; Bolevich S; Orlova A; Mikhaleva A; Kartashova A; Yavlieva K; Nikolic Turnic T; Pindovic B; Djordjevic K; Srejovic I; Zivkovic V; Jakovljevic V
    Animals (Basel); 2023 Sep; 13(18):. PubMed ID: 37760247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacing Insulin Glargine with Neutral Protamine Hagedorn (NPH) Insulin in a Subpopulation of Study Subjects in the Action to Control Cardiovascular Risk in Diabetes (ACCORD): Effects on Blood Glucose Levels, Hypoglycemia and Patient Satisfaction.
    Berard L; Cameron B; Woo V; Stewart J
    Can J Diabetes; 2015 Aug; 39(4):296-301. PubMed ID: 25819531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics and metabolic activity of biosynthetic NPH insulin evaluated by the glucose clamp technique.
    Massi Benedetti M; Bueti A; Mannino D; Bellomo G; Antonella MA; Calabrese G; Zega G; Brunetti P
    Diabetes Care; 1984; 7(2):132-6. PubMed ID: 6376009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin glargine: a systematic review of a long-acting insulin analogue.
    Wang F; Carabino JM; Vergara CM
    Clin Ther; 2003 Jun; 25(6):1541-77, discussion 1539-40. PubMed ID: 12860485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A study of the absorption of NPH insulin administered into subcutaneous tissue: in vitro study of the mechanism of insulin release from NPH insulin crystal].
    Yanagisawa K
    Hokkaido Igaku Zasshi; 1992 Jan; 67(1):81-8. PubMed ID: 1559663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of insulin on urinary calcium excretion by diabetic rats in the absence of blood glucose control.
    Hoskins B; Scott JM
    Acta Diabetol Lat; 1984; 21(3):263-73. PubMed ID: 6393675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic analysis of anaphylaxis to protamine component in neutral protamine Hagedorn human insulin.
    Dykewicz MS; Kim HW; Orfan N; Yoo TJ; Lieberman P
    J Allergy Clin Immunol; 1994 Jan; 93(1 Pt 1):117-25. PubMed ID: 8308177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
    Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
    J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.